![The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy--an open-label, prospective, randomised controlled multicenter study]()
The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy--an open-label, prospective, randomised controlled multicenter studyRosenow, F.; Schade-Brittinger, C.; Burchardi, N.; Bauer, S.; Klein, K. M.; Weber, Y.; Lerche, H.; Evers, S.; Kovac, S.; Hallmeyer-Elgner, S.; Winkler, G.; Springub, J.; Niedhammer, M.; Roth, E.; Eisensehr, I.; Berrouschot, J.; Arnold, S.; Schroder, M.; Beige, A.; Oertel, W. H.; Strzelczyk, A.; Haag, A.; Reif, P. S.; Hamer, H. M. · Journal of Neurology, Neurosurgery & Psychiatry · 2012